GVS S.P.A. |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.51 EUR | 0.00% |
|
-0.54% | -1.17% |
| Apr. 09 | Mib correction at 34,000; strength on Fincantieri | AN |
| Apr. 09 | Lists bearish; DiaSorin rises against the tide | AN |
| Sales 2024 * | 445M 478M | Sales 2025 * | 469M 503M | Capitalization | 963M 1.03B |
|---|---|---|---|---|---|
| Net income 2024 * | 40M 42.93M | Net income 2025 * | 55M 59.04M | EV / Sales 2024 * | 2.8 x |
| Net Debt 2024 * | 282M 303M | Net Debt 2025 * | 226M 242M | EV / Sales 2025 * | 2.54 x |
| P/E ratio 2024 * |
23.9
x | P/E ratio 2025 * |
17.6
x | Employees | 4,386 |
| Yield 2024 * |
-
| Yield 2025 * |
1.32% | Free-Float | 36.74% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 week | -0.54% | ||
| Current month | -8.93% | ||
| 1 month | -8.93% | ||
| 3 months | -5.89% | ||
| 6 months | +34.85% | ||
| Current year | -1.17% |
1 week
5.37
5.62
1 month
5.376.28
Current year
5.146.96
1 year
4.006.96
3 years
2.9217.11
5 years
2.9217.67
10 years
2.9217.67
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 84-12-31 | |
Marco Pacini
DFI | Director of Finance/CFO | - | 22-12-31 |
Matteo Viola
COO | Chief Operating Officer | 49 | 07-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Alessandro Nasi
CHM | Chairman | 50 | 20-03-12 |
| Chief Executive Officer | 58 | 84-12-31 | |
Pietro Cordova
BRD | Director/Board Member | - | 23-05-02 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 773 M€ | -.--% | - | |
| 0.00% | 10 M€ | -3.35% | - | |
| 0.00% | 34 M€ | +2.04% | - | |
| 0.00% | 7 M€ | +0.11% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-02 | 5.51 | +0.55% | 49,118 |
| 24-04-30 | 5.48 | -1.44% | 69,668 |
| 24-04-29 | 5.56 | +1.83% | 68,503 |
| 24-04-26 | 5.46 | +1.30% | 44,998 |
| 24-04-25 | 5.39 | -2.00% | 95,643 |
Real-time Borsa Italiana, May 02, 2024 at 11:44 am EDT
More quotes
GVS SpA is an Italy-based manufacturer of filters and components for applications in the healthcare, life sciences, automotive, appliance, safety, commercial and industrial filtration. Its offering includes seven product lines: Healthcare, Laboratory, Mobility, Air Safety, Appliance, Personal Safety and Membranes. Each product line provides a suite of customizable solutions specifically related to each market. Additionally, the Company offers tailormade product and process development services, which cover all the project stages, including product and process design, validation, up to the mass production for large quantities. It is active globally.
Calendar
2024-05-07
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
5.51
EUR
Average target price
6.367
EUR
Spread / Average Target
+15.55%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -1.17% | 1.03B | |
| +8.96% | 27.12B | |
| -30.49% | 3.07B | |
| -15.97% | 2.52B | |
| +18.11% | 2.47B | |
| +3.70% | 2B | |
| -9.47% | 1.91B | |
| -2.22% | 1.47B | |
| +2.24% | 1.33B | |
| +18.92% | 1.19B |
- Stock Market
- Equities
- GVS Stock
